Aquablation Pilot Study for the treatment of Benign Prostatic Hyperplasia.

Not Applicable

Active, not recruiting

• Conditions: Benign Prostatic Hyperplasia (BPH) otherwise known as enlarged prostate due to benign growth of glandular tissue; Surgery - Surgical techniques; Renal and Urogenital - Other renal and urogenital disorders

• Registration Number: ACTRN12613000167763
• Lead Sponsor: PROCEPT BioRobotics Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-02-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

Male, Age > 50 years with BPH and history of inadequate response to medical therapy.

Exclusion Criteria

Large median lobe, urethral length >6cm, prostates >80g, prostate cancer, current urological conditions affecting procedural outcomes, previous prostate surgery, significant renal impairment, listed concomitant medications and listed uncontrolled co-morbidities.

Study & Design

• Study Type: Interventional
• Study Design: Not specified